This compound is widely utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). It serves as a key linker component, connecting the E3 ligase ligand to the target protein ligand, enabling the selective degradation of disease-causing proteins. Its application is critical in cancer research, where it helps in designing molecules that can degrade oncogenic proteins, offering potential therapeutic benefits. Additionally, it is used in biochemical studies to understand protein-protein interactions and cellular pathways, contributing to advancements in drug discovery and development.